James J H Rucker (James Rucker, James J Rucker)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 29

Top Venues

Journal of psychopharmacology (Oxford, England)

BMJ open

Neuropsychiatric disease and treatment

BJPsych bulletin

King's College London

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King's College London Jan 03 2018

United Kingdom

Senior Clinical Lecturer :: Centre for Affective Disorders

Publications

Charlie Song-Smith, Edward Jacobs, James J H Rucker, Matthew Saint, James Cooke, Marco Schlosser
UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study. BMJ open 14 (3) (2024)
Charlie Song-Smith, Edward Jacobs, James J H Rucker, Matthew Saint, James Cooke, Marco Schlosser
UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study. BMJ open 14 (3) (2024)
Charlie Song-Smith, Edward Jacobs, James J H Rucker, Matthew Saint, James Cooke, Marco Schlosser
UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study. BMJ open 14 (3) (2024)
Nadav Liam Modlin, Michael Creed, Maria Sarang, Carolina Maggio, James J H Rucker, Victoria Williamson
Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions. Neuropsychiatric disease and treatment 20 (2024)
Charlie Song-Smith, Edward Jacobs, James J H Rucker, Matthew Saint, James Cooke, Marco Schlosser
UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study. BMJ open 14 (3) (2024)
Nadav Liam Modlin, Michael Creed, Maria Sarang, Carolina Maggio, James J H Rucker, Victoria Williamson
Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions. Neuropsychiatric disease and treatment 20 (2024)
Anya Borissova, James J H Rucker
The development of psilocybin therapy for treatment-resistant depression: an update. BJPsych bulletin (2023)
Kwonmok Ko, Ben Carter, Anthony J Cleare, James J H Rucker
Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis. Neuropsychiatric disease and treatment 19 (2023)
Lara Bapir, Simon Erridge, Martha Nicholas, Manaswini Pillai, Nishaanth Dalavaye, Carl Holvey, Ross Coomber, Jonathan Hoare, Shaheen Khan, Mark W Weatherall, James J H Rucker, Michael Platt, Mikael Hans Sodergren
Comparing the Effects of Medical Cannabis for Chronic Pain Patients With and Without Co-Morbid Anxiety: A Cohort Study. Expert review of neurotherapeutics (2023)
Emma I Kopra, Jason A Ferris, Adam Rohan Winstock, Kim Paula Colette Kuypers, Allan H Young, James J H Rucker
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020. Journal of psychopharmacology (Oxford, England) (2023)
James J H Rucker
Psilocybin therapy for depression. A good trip? Journal of mental health (Abingdon, England) 32 (1) (2023)
Sameer Jauhar, Danilo Arnone, David S Baldwin, Michael A P Bloomfield, Michael Browning, Anthony J Cleare, Philip Robert Corlett, John Francis William Deakin, David Erritzøe, Cynthia H Y Fu, Paolo Fusar-Poli, Guy M Goodwin, Joseph Hayes, Robert Howard, Oliver D Howes, Mário Francisco Juruena, Raymond W Lam, Stephen M Lawrie, Hamish McAllister-Williams, Steven Marwaha, David Matuskey, Robert A McCutcheon, David John Nutt, Carmine Maria Pariante, Toby Pillinger, Rajiv Radhakrishnan, James J H Rucker, Sudhakar Selvaraj, Paul Stokes, Rachel Upthegrove, Nefize Yalin, Lakshmi Yatham, Allan H Young, Roland Zahn, Philip J Cowen
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression. Molecular psychiatry (2023)
James J H Rucker
Evidence versus expectancy: the development of psilocybin therapy. BJPsych bulletin (2023)
Luke A Jelen, Upeka de Silva, James J H Rucker, Allan H Young
RE: Proposed Assisted Dying Bill: implications for mental healthcare and psychiatrists. The British journal of psychiatry : the journal of mental science 222 (4) (2023)
Lara Bapir, Simon Erridge, Martha Nicholas, Manaswini Pillai, Nishaanth Dalavaye, Carl Holvey, Ross Coomber, Jonathan Hoare, Shaheen Khan, Mark W Weatherall, James J H Rucker, Michael Platt, Mikael Hans Sodergren
Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study. Expert review of neurotherapeutics (2023)
Mehmet Ergisi, Simon Erridge, Michael Harris, Michal Kawka, Devaki Nimalan, Oliver Salazar, Katerina Loupasaki, Rayyan Ali, Carl Holvey, Ross Coomber, Michael Platt, James J H Rucker, Mikael H Sodergren
UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder. Expert review of clinical pharmacology 15 (4) (2022)
James J H Rucker, Lindsey Marwood, Riikka-Liisa J Ajantaival, Catherine Bird, Hans Eriksson, John Harrison, Molly Lennard-Jones, Sunil Mistry, Francesco Saldarini, Susan Stansfield, Sara J Tai, Sam Williams, Neil Weston, Ekaterina Malievskaia, Allan H Young
The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation. Journal of psychopharmacology (Oxford, England) 36 (1) (2022)
Chaitra Jairaj, James J H Rucker
Postpartum depression: A role for psychedelics? Journal of psychopharmacology (Oxford, England) 36 (8) (2022)
Emma I Kopra, Jason A Ferris, Adam Rohan Winstock, Allan H Young, James J H Rucker
Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Journal of psychopharmacology (Oxford, England) 36 (8) (2022)
Emma I Kopra, Jason A Ferris, James J H Rucker, Benjamin McClure, Allan H Young, Caroline S Copeland, Adam Rohan Winstock
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD). Journal of psychopharmacology (Oxford, England) 36 (8) (2022)
Vera M Ludwig, Cathrin Sauer, Allan H Young, James J H Rucker, Michael Bauer, Hannelore Findeis, Philipp S Ritter
Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study. CNS drugs 35 (8) (2021)
Matthew Butler, Oliver Shipston-Sharman, Mathieu Seynaeve, Jianan Bao, Susannah Pick, Abigail Bradley-Westguard, Eveliina Ilola, Bridget Mildon, Dawn Golder, James J H Rucker, Jon Stone, Timothy Nicholson
International online survey of 1048 individuals with functional neurological disorder. European journal of neurology 28 (11) (2021)
James J H Rucker, Hassan Jafari, Tim Mantingh, Catherine Bird, Nadav Liam Modlin, Gemma Knight, Frederick Reinholdt, Camilla Day, Ben Carter, Allan Young
Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial. BMJ open 11 (12) (2021)
Ida Elken Sonderby, Dennis van der Meer, Clara A Moreau, Tobias Kaufmann, G Bragi Walters, Maria Ellegaard, Abdel Abdellaoui, David Ames, Katrin Amunts, Micael Andersson, Nicola J Armstrong, Manon Bernard, Nicholas B Blackburn, John E Blangero, Dorret I Boomsma, Henry Brodaty, Rachel M Brouwer, Robin Bülow, Rune Bøen, Wiepke Cahn, Vince D Calhoun, Svenja Caspers, Christopher R K Ching, Sven Cichon, Simone Ciufolini, Benedicto Crespo-Facorro, Joanne E Curran, Anders M Dale, Shareefa Dalvie, Paola Dazzan, Eco J C N de Geus, Greig I de Zubicaray, Sonja M C de Zwarte, Sylvane Desrivieres, Joanne L Doherty, Gary Donohoe, Bogdan Draganski, Stefan Ehrlich, Else Eising, Thomas Espeseth, Kim Fejgin, Simon E Fisher, Tormod Fladby, Oleksandr Frei, Vincent Frouin, Masaki Fukunaga, Thomas Gareau, Tian Ge, David C Glahn, Hans Jörgen Grabe, Nynke A Groenewold, Ómar Gústafsson, Jan Haavik, Asta K Haberg, Jeremy Hall, Ryota Hashimoto, Jayne Y Hehir-Kwa, Derrek P Hibar, Manon H J Hillegers, Per Hoffmann, Laurena Holleran, Avram J Homes, Georg Homuth, Jouke- Jan Hottenga, Hilleke E Hulshoff Pol, Kyung Sue Hong, Neda Jahanshad, Christiane Jockwitz, Stefan E Johansson, Erik G Jönsson, Niklas R Jørgensen, Masataka Kikuchi, Emma E M Knowles, Kuldeep Kumar, Stephanie Le Hellard, Costin Leu, David E J Linden, Jingyu Liu, Arvid Lundervold, Astri Johansen Lundervold, Anne Manuela Maillard, Nicholas G Martin, Sandra Martin-Brevet, Karen A Mather, Samuel R Mathias, Katie L Mcmahon, Allan F McRae, Sarah E Medland, Andreas Meyer-Lindenberg, Torgeir Moberget, Claudia Modenato, Jennifer Monereo Sánchez, Derek W Morris, Thomas W Mühleisen, Robin M Murray, Jacob Nielsen, Jan E Nordvik, Lars Nyberg, Loes M Olde Loohuis, Roel A Ophoff, Michael J Owen, Tomáš Paus, Zdenka Pausova, Juan M Peralta, Gilbert Bruce Pike, Carlos Prieto, Erin Burke Quinlan, Céline S Reinbold, Tiago Reis Marques, James J H Rucker, Perminder Singh Sachdev, Sigrid B Sando, Peter R Schofield, Andrew J Schork, Gunter Schumann, Jean Shin, Elena Shumskaya, Ana Isabel Silva, Sanjay M Sisodiya, Vidar M Steen, Dan J Stein, Lachlan T Strike, Ikuo K Suzuki, Christian K Tamnes, Alexander Teumer, Anbupalam Thalamuthu, Diana Tordesillas-Gutiérrez, Anne Uhlmann, Magnus O Ulfarsson, Dennis van 't Ent, Marianne B M van den Bree, Pierre Vanderhaeghen, Evangelos Vassos, Wei Wen, Katharina Wittfeld, Margaret J Wright, Ingrid Agartz, Srdjan Djurovic, Lars Tjelta Westlye, Hreinn Stefánsson, Kári Stefánsson, Sebastien Jacquemont, Paul M Thompson, Ole Andreas Andreassen, null null
1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans. Translational psychiatry 11 (1) (2021)
Michael Harris, Simon Erridge, Mehmet Ergisi, Devaki Nimalan, Michal Kawka, Oliver Salazar, Rayyan Ali, Katerina Loupasaki, Carl Holvey, Ross Coomber, Azfer Usmani, Mohammed Sajad, Jonathan Hoare, James J H Rucker, Michael Platt, Mikael Hans Sodergren
UK Medical Cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions. Expert review of clinical pharmacology 15 (4) (2021)
Anna O Ermakova, Fiona Dunbar, James J H Rucker, Matthew W Johnson
A narrative synthesis of research with 5-MeO-DMT. Journal of psychopharmacology (Oxford, England) (2021)
Benjamin Jg Illingworth, Declan J Lewis, Andrew T Lambarth, Kate Stocking, James Mn Duffy, Luke A Jelen, James J H Rucker
A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis. Journal of psychopharmacology (Oxford, England) 35 (5) (2020)
Matthew Butler, Mathieu Seynaeve, Timothy R Nicholson, Susannah Pick, Richard A Kanaan, Andrew Lees, Allan H Young, James J H Rucker
Psychedelic treatment of functional neurological disorder: a systematic review. Therapeutic advances in psychopharmacology 10 (2020)
Neil M Weston, Damian Gibbs, Catherine I V Bird, Aster Daniel, Luke A Jelen, Gemma Knight, David Goldsmith, Allan H Young, James J H Rucker
Historic psychedelic drug trials and the treatment of anxiety disorders. Depression and anxiety 37 (12) (2020)

James J H Rucker.css-eqlu8i{font-size:small;padding-left:4px;} (James Rucker, James J Rucker)

Publication Activity (10 Years)

Top Topics

Top Venues

James J H Rucker (James Rucker, James J Rucker)